Acasti Pharma Inc.
ACST
$0.54
$0.00280.52%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
5/17/2023
-
PR Newswire
5/8/2023
-
PR Newswire
4/4/2023
-
Seeking Alpha - Healthcare
4/4/2023
-
PR Newswire
4/4/2023
-
PR Newswire
3/31/2023
-
Zolmax
3/30/2023
-
PR Newswire
3/30/2023
-
Ticker Report
3/13/2023
-
Zolmax
3/13/2023
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 14, 2023
Period Date
Saturday, December 31, 2022
Next Filing
Week of Jun 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
450 687 2262
Address
3009 boulevard de la Concorde East
Laval, QC H7E 2B5
Laval, QC H7E 2B5
Country
Year Founded
Business Description
Sector
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships...
more
